Aeluma, Inc. (AELU) - Q3 2024 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended September 30, 2024. Aeluma, Inc. is a smaller reporting company and emerging growth company engaged in the research and development of infrared (IR) optical sensors. The company aims to disrupt the IR sensor market by producing high-performance alternatives to low-cost sensors using proprietary compound semiconductor technology. Primary target markets include 3D imaging, LiDAR, and defense/aerospace applications.
Key Financial Metrics
| Metric | Q3 2024 | Q3 2023 |
|---|---|---|
| Revenue | $480,735 | $32,400 |
| Net Loss | $(729,619) | $(1,482,309) |
| Loss Per Share (Basic/Diluted) | $(0.06) | $(0.12) |
| Operating Cash Flow | $(931,915) | $(1,303,362) |
| Cash and Cash Equivalents (End of Period) | $3,502,520 | $3,757,227 |
| Total Assets | $6,348,859 | $3,844,047 |
| Total Liabilities | $4,635,226 | $1,567,886 |
| Convertible Notes (Principal) | $3,145,000 | $0 |
| Derivative Liabilities | $2,046,695 | $0 |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased by $448,335 (1,384% increase) driven primarily by government contracts ($430,735) compared to the prior year which was solely commercial product sales.
- Reduced Net Loss: Net loss decreased by 50.8% to $729,619, attributed to a 20% reduction in operating expenses despite higher revenue.
- Debt Financing: The company issued $3.145 million in convertible promissory notes in August 2024. This resulted in a significant increase in current liabilities due to the recognition of $2.05 million in derivative liabilities associated with the notes.
- Liquidity Improvement: Cash and cash equivalents increased by $2.21 million during the quarter, primarily due to proceeds from the convertible note issuance.
Outlook, Risks, and Management Commentary
- Going Concern: The filing explicitly states that conditions raise substantial doubt about the company's ability to continue as a going concern. The company has an accumulated deficit of $14.35 million and requires additional capital infusions to fund operations and development.
- New Contracts: In September 2024, the company was awarded a $11.7 million DARPA contract for nano-scale semiconductors. Revenue from this contract will be recognized over 36 months as milestones are met.
- Convertible Notes Terms: The new notes mature in June 2026, carry no interest, and convert to common stock upon a qualified financing, uplisting, or maturity. They include a floor price (approx. $2.68) and a ceiling price ($3.50).
- Internal Controls: Management concluded that disclosure controls and procedures were not effective as of September 30, 2024, citing insufficient staffing in the finance department to support the complexity of financial reporting.
- Customer Concentration: Revenue is heavily concentrated in government agencies, with Customer A representing 35.8% of Q3 2024 revenue.
Investor Verification Checklist
- Cash Runway: Verify if the current cash balance of $3.5 million is sufficient to fund operations until the next anticipated financing or revenue milestone, given the "going concern" warning.
- Dilution Risk: Assess the potential dilution from the $3.145 million convertible notes, specifically the conversion mechanics (85% of VWAP) and the impact of the derivative liabilities on future equity.
- Revenue Recognition: Confirm the timeline for revenue recognition on the $11.7 million DARPA contract and the specific milestones required to unlock the remaining $5.7 million.
- Internal Controls: Monitor future filings for remediation plans regarding the ineffective disclosure controls and procedures.
- Derivative Liability Volatility: Track the fair value of the $2.05 million derivative liability, as changes in stock price will directly impact net income/loss in future periods.